Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03709706 |
| Title | Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells Specific in NY-ESO-1/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | GBR | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | La Jolla | California | 92093-0987 | United States | Details | |
| GSK Investigational Site | Sacramento | California | 95817 | United States | Details | |
| GSK Investigational Site | Stanford | California | 94305 | United States | Details | |
| GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
| GSK Investigational Site | Hollywood | Florida | 33021 | United States | Details | |
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Chicago | Illinois | 60637 | United States | Details | |
| GSK Investigational Site | Iowa City | Iowa | 52242 | United States | Details | |
| GSK Investigational Site | Lexington | Kentucky | 40536 | United States | Details | |
| GSK Investigational Site | Baltimore | Maryland | 21201 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Durham | North Carolina | 27710 | United States | Details | |
| GSK Investigational Site | Columbus | Ohio | 43210 | United States | Details | |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19111 | United States | Details | |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | Salt Lake City | Utah | 84112-5550 | United States | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 1X6 | Canada | Details | |
| GSK Investigational Site | Montréal | Quebec | H2X 0A9 | Canada | Details | |
| GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
| GSK Investigational Site | Groningen | 9713 GZ | Netherlands | Details | ||
| GSK Investigational Site | Rotterdam | 3015 GD | Netherlands | Details | ||
| GSK Investigational Site | Utrecht | 3584 CX | Netherlands | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28050 | Spain | Details | ||
| GSK Investigational Site | London | WC1E 6AG | United Kingdom | Details | ||
| GSK Investigational Site | Manchester | M20 4BX | United Kingdom | Details |